Immunology
-
De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )
This article has 7 authors:Reviewed by ScreenIT
-
Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy
This article has 4 authors:Reviewed by ScreenIT
-
Currently available intravenous immunoglobulin (Gamunex ® -C and Flebogamma ® DIF) contains antibodies reacting against SARS-CoV-2 antigens
This article has 3 authors:Reviewed by ScreenIT
-
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition
This article has 4 authors:Reviewed by ScreenIT
-
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome
This article has 16 authors:Reviewed by ScreenIT
-
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
This article has 22 authors:Reviewed by ScreenIT
-
Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development
This article has 3 authors:Reviewed by ScreenIT
-
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity
This article has 4 authors:Reviewed by ScreenIT
-
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes
This article has 4 authors:Reviewed by ScreenIT
-
Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach
This article has 5 authors:Reviewed by ScreenIT